Dr Bikash Kumar Nayak, Plant Head, Aurobindo Pharma
Vizag Pharma Summit 2022 | 27th May 2022 | The Gateway Hotel, Visakhapatnam
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Valedictory Session: Rameswara Sharma Vedula, Associate VP – Materials Management, Escientia…
Vizag Pharma Summit 2022 | 27th May 2022 | The Gateway Hotel, Visakhapatnam
AstraZeneca India extends programme on cancer-screening for women in TN
The project aims at early detection of oral, breast and cervical cancer, especially in women below poverty line
GC Troubleshooting – Now in the palm of your hand
Now It’s Easy to Keep Your GC Analysis at Full Flow
Every GC analyst knows that leaks can damage consumables and cause…
Merck presents positive results from phase-II/III study
Broad phase-III clinical programme for V116 in vaccine-naïve and vaccine-experienced adults planned to start in July 2022
Ocugen announces positive results for COVID-19 vaccine trial for children aged two-18 years
Ocugen’s partner Bharat Biotech’s phase-II/III study of Covaxin (BBV152) in 526 children showed safety, efficacy, and superior…
Moderna to build new vaccine facility in Britain
Britain's health ministry said that the pandemic had shown mRNA technology as one of the fastest routes to develop new vaccines,…
Biocon Biologics denies bribery allegations
A statement from the company claimed that besides its employees, all its consultants, suppliers and partners are also bound by a…
OPPI appoints Vivek Sehgal as new Director General
Sehgal has close to three decades of cross-sectoral experience on policy issues with central/state governments, regulators and…
AstraZeneca and Ionis eye US approval after positive trial data
Based on the results, the companies plan to file an application to market the therapy in the US later this year in patients with…